Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	a. Patients with oxygen saturation (SPO2) less than 95% <br/ >b. Respiratory rate is more than 20/min <br/ >c. Pulse rate more than 90/min <br/ >d. Imaging evidence of lung infection in the form of Reticulonodular opacities, ground-glass opacities, consolidation and Acute Respiratory Distress Syndrome (ARDS) <br/ >	a. Patients with oxygen saturation (SPO2) less than 95% <br/ >b. Respiratory rate is more than 20/min <br/ >c. Pulse rate more than 90/min <br/ >d. Imaging evidence of lung infection in the form of Reticulonodular opacities, ground-glass opacities, consolidation and Acute Respiratory Distress Syndrome (ARDS) <br/ >
Nov. 13, 2021, 5:33 p.m.	oms
Oct. 26, 2020, 8:29 a.m.	oms	a. Patients with oxygen saturation (SPO2) less than 95% <br/ >b. Respiratory rate is more than 20/min <br/ >c. Pulse rate more than 90/min <br/ >d. Imaging evidence of lung infection in the form of Reticulonodular opacities, ground-glass opacities, consolidation and Acute Respiratory Distress Syndrome (ARDS) <br/ >	a. Patients with oxygen saturation (SPO2) less than 95% <br/ >b. Respiratory rate is more than 20/min <br/ >c. Pulse rate more than 90/min <br/ >d. Imaging evidence of lung infection in the form of Reticulonodular opacities, ground-glass opacities, consolidation and Acute Respiratory Distress Syndrome (ARDS) <br/ >